1) Ono K, Kuwabara Y, Han J:MicroRNAs and cardiovascular diseases. FEBS J 2011;278:1619-1633
2) Horie T, Baba O, Kuwabara Y, et al:MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE(-/-) Mice. J Am Heart Assoc 2012;1:e003376
3) Nakao T, Horie T, Baba O, et al:Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways. Arterioscler Thromb Vasc Biol 2017;37:2161-2170
4) Nishiga M, Horie T, Kuwabara Y, et al:MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol. Circ Res 2017;120:835-847
5) Nishino T, Horie T, Baba O, et al:SREBF1/MicroRNA-33b Axis Exhibits Potent Effect on Unstable Atherosclerotic Plaque Formation In Vivo. Arterioscler Thromb Vasc Biol 2018;38:2460-2473